FIELD: cholecystic diseases. SUBSTANCE: level of malonic dialdehyde in chloroform- methanol extract of patientТs bile is determined as nmols of dialdehyde per 1 ml of bile using reaction with thiobarbituric acid in an acidic waterless medium. Simultaneously, in the same extract, content of phospholipides in mg/ml (of bile) is determined. When ratio of malonic dialdehyde content to thiobarbituric acid content is higher than 5.0 nmol/mg, cholecystitis exacerbation is diagnosed. EFFECT: increased accuracy of the method due to avoiding effect of liver and non-lipid component concentration factor. 1 tbl, 1 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD OF DIAGNOSING LIVER FAILURE | 1995 |
|
RU2123185C1 |
| METHOD OF INVESTIGATING METABOLISM OF MALONIC DIALDEHYDE IN ERYTHROCYTES | 0 |
|
SU1388805A1 |
| METHOD FOR DETECTING VELOCITY IN DEVELOPMENT OF LIPID PEROXIDATION PRODUCTS IN ERYTHOCYTIC MEMBRANES IN FARM ANIMALS | 2002 |
|
RU2229133C1 |
| METHOD FOR DIAGNOSING CHRONIC ENDOMETRITIS IN WOMEN WITH INFERTILITY | 2022 |
|
RU2794331C1 |
| EARLY DIAGNOSTIC TECHNIQUE FOR PRIMARY OPEN-ANGLE GLAUCOMA AND PRE-GLAUCOMA | 2012 |
|
RU2513476C1 |
| METHOD FOR DIAGNOSING PURULENT NECROTIC COMPLICATIONS IN THE CASES OF PANCREATIC NECROSIS | 2000 |
|
RU2199121C2 |
| METHOD FOR PREDICTING THE BRAIN TRAUMA DISEASE DEVELOPMENT COURSE | 2001 |
|
RU2178179C1 |
| ESTIMATE OF DISEASE SEVERITY AND INDICATIONS FOR ANTIOXIDANT THERAPY IN PATIENTS SUFFERING FROM CHRONIC CEREBRAL ISCHEMIA | 2007 |
|
RU2357253C2 |
| METHOD FOR PREDICTION OF CLINICAL COURSE OF CEREBRAL WOUND DYSTROPHY | 2010 |
|
RU2426992C1 |
| METHOD FOR DETERMINING MALONIC DIALDEHYDE CONCENTRATION BY USING THIOBARBITURIC ACID | 1995 |
|
RU2112241C1 |
